CBL
CONTROL BIONICS LIMITED
$0.0510
▼ -3.77%
Market cap
$28M
Turnover
$18,199
Last price
$0.0510
Day change
-3.77%
Announcements
13
Range, past year
Open 0.061 · Low 0.026 · Now 0.051 · High 0.095
Open CBL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
CBL momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-11-16.
Momentum quality
30/100
Wyckoff phase
Accumulation4d
Trend stage
Neutral
1 Day
-3.8%
1 Week
+2.0%
1 Month
-12.1%
1 Year
-21.5%
RSI
43
Avg daily range
4.9%
CONTROL BIONICS LIMITED scores 30 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 4 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -25.8%
- Thin liquidity
- Risk rating: High
- Composite downside risk elevated
CBL announcements
Recent price-sensitive releases.
- 2026-10-29 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
- 2026-08-28 Preliminary Final Report Preliminary Final Report
- 2026-08-27 Medicare Billing Code Secured for NextLevel Speech Devices Progress Report
- 2026-08-25 NeuroStrip secures MHRA registration Progress Report
- 2026-08-04 US FDA Registration and Device Listing for NeuroStrip Progress Report
- 2026-07-31 Commercial momentum builds across both platform pillars Progress Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
More Health Care stocks
Most traded in the same sector.